Article
Pharmacogenomics of cyclooxygenases.
Pharmacogenomics - 1 Jan 2015
Agúndez José A G, Blanca Miguel, Cornejo-García José A, García-Martín Elena
Abstract excerpt
Cyclooxygenases (COX-1 and COX-2) are key enzymes in several physiopathological processes. Many adverse drugs reactions to NSAIDs are attributable to COX-inhibition. The genes coding for these enzymes (PTGS1 and PTGS2) are highly variable, and variations in these genes may underlie the risk of developing, or the clinical evolution of, several diseases and adverse drug reactions. We analyze major variations in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
